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INTRODUCTION 
Mastalgia is the most common breast symptom in patients 
attending any breast clinic1. About 60 to 70 % of women experience 
some degree of mastalgia, among them 10 to 20 % of cases present with 
severe pain 2, 3. The common concerns of patients coming with mastalgia 
in OPD are: the fear of cancer and the severe degree of pain affecting 
day to day activity. The majority of patients with mastalgia can be 
managed with  either reassurance or simple drugs. Mastalgia in 
significant proportion of patients is associated with breast nodularity 
that may be tender or without a clinically palpable lump. Some degree 
of mastalgia and breast nodularity are found in normal population 3, 4. 
The most important responsibility of the clinician is to rule out benign 
breast disease or cancer and to reassure the patient.  
 In addition most of the causes of mastalgia are poorly 
understood, inadequately assessed and treated. Knowing the magnitude 
of the problem there is a need to conduct clinicopathological study on 
mastalgia. The purpose of the study is to profile the natural history, 
different modes of clinical presentation, to study with respect to various 
radiological and pathological presentations so that we can make any 
alteration in treatment and approach. Also we want to correlate the 
clinical diagnosis with histopathological diagnosis. 
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AIMS AND OBJECTIVES OF THE STUDY: 
 To study the natural history and different modes of clinical presentation 
of mastalgia. 
 To study the various radiological and pathological patterns of mastalgia. 
 To correlate clinical diagnosis with the histopathological diagnosis in 
order to refine our diagnostic skills  
SOURCE OF THE DATA: 
Patients attending the surgery department of Tirunelveli medical college 
hospital, with complaints of mastalgia during December 2016 to 
September 2018. 
 STUDY DESIGN: 
A prospective cohort study of a sample size of 200 patients fulfilling the 
inclusion criteria will be part of this study. 
INCLUSION CRITERIA: 
 Patients above 13years of age who present with complaints of 
mastalgia with or without lump or nipple discharge. 
 Lactating women. 
 Patients who are willing for follow up. 
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EXCLUSION CRITERIA: 
 Patients with signs and symptoms suggestive of carcinoma breast. 
 Pregnant patients. 
 Patients who are not willing for follow up. 
METHOD OF COLLECTION OF DATA: 
 All the patients coming to TVMCH surgery dept. with the features 
suggestive of mastalgia will be subjected to detailed history and clinical 
examination. 
 All the patients will be subjected to ultra sonography, mammography 
(only in patients more than 40yrs of age), FNAC (as and when required) 
besides routine investigations. 
 The patients who has lump and in whom surgery is contemplated will 
undergo excisional biopsy and histopathological examination of 
excised lump. 
INVESTIGATION AND INTERVENTION: 
 Routine blood investigations-HB%, TC, DC, ESR, RBS, 
Urea, Creatinine. 
 Ultrasonography of the breasts 
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 Mammography as and when required (Mammography for 
patients above the age of 40yrs). 
  FNAC and Excisional biopsy as and when required. 
 Pus culture and sensitivity in case of breast abscess. 
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REVIEW OF LITERATURE 
CLASSIFICATION OF BREAST PAIN 
CYCLICAL MASTALGIA 
Cyclical breast pain tends to occur 1 to 2 weeks before menses. The 
pain is diffuse and bilateral, at times radiating to the upper arm and axilla. 
Some experience more severe pain in one breast than the other. It is usually 
relieved by the onset of menstrual flow. Cyclical mastalgia affects age 
group between 30 and 40. Cyclical mastalgia may have spontaneous 
resolution in 22 % of patients and persists in up to 65 % of patients even 
after treatment 4. However, it can resolve with a pregnancy or menopause, 
and because of this, it is postulated that cyclical mastalgia may occur due 
to hormonal stimulation of breast parenchyma  at the end of the luteal phase 
of the menstrual cycle 5. For many, it may be a lifelong suffering till they 
attain menopause, if left untreated 4. 
NONCYCLICAL MASTALGIA 
 It is usually unilateral and at times localized to one quadrant of the 
breast. Affecting the elderly age group, in their 40s or 50s, and are often 
perimenopausal 5. There causes of noncyclical mastalgia are periductal 
mastitis ,cysts, Mondor’s disease, traumatic fat necrosis, stretching of 
Cooper’s ligaments , diabetic mastopathy, and neoplasia 3, 5. 
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In up to 50 % of cases it can resolve without treatment but in others it’s 
more difficult to treat 3. 
Chest wall pain can mimic mastalgia. Common causes of chest wall 
pain are costochondritis (Teitze’s disease), herpes zoster and referred nerve 
root pain as in cervical spondylitis. Non-chest wall pain can be due to 
ischemic heart disease, peptic ulcer and biliary pain. 5, 6. 
ETIOLOGY OF MASTALGIA 
ENDOCRINE ABNORMALITIES 
Three main theories postulated: 
1. Increased estrogen secretion from the ovary 
2. Deficient progesterone production 
3. Hyperprolactinemia 
The serum hormone levels studies do not support the first two 
postulates, as hormonal levels are similar in both patient group and control 
group7  however, a recent study published  showed a significantly 
depressed level of luteal progesterone, thus supporting the second theory 
12. 
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It is found that the patients with mastalgia had a significantly greater rise 
in prolactin  levels when compared to the control groups . A study 
conducted at Cardiff Mastalgia Clinic also arrived at a result of rise in 
stimulated prolactin level in women presenting with mastalgia11 . 
WATER RETENTION 
In the study conducted at Cardiff  Mastalgia Clinic, the total amount 
of body water was measured using radioactive water (D2O) in mastalgia 
patients and control groups women. It was observed that there was no 
significant differences in water gain in mastalgia patients compared to 
control group  in between the 5th and 25th day of menstrual cycle13. So the 
study concluded that simple retention of body water is not associated with 
breast pain 13. 
PSYCHONEUROSIS 
Astley Copper suggested that some patients presenting with 
mastalgia were neurotic. A Middlesex Hospital Questionnaire (MHQ) 
analysed psycho - neurotic profiles of 300 patients with mastalgia( both 
cyclical and noncyclical) and 156 patients with varicose veins. The MHQ 
scores of patients presented with mastalgia were  significantly lower than  
those of neurotic patients, thus showing no correlation of psychoneurosis 
in occurrence of mastalgia 14. 
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CAFFEINE AND METHYLXANTHINE 
It is suggested that breast cells overstimulation may occur due to 
interference with adenosine triphosphate degradation  pathway by 
methylxanthine. Minton et al. observed that caffeine restriction produced 
improvement in symptoms; however, the study was uncontrolled15 . 
Subsequent randomized control trials have failed to demonstrate the 
benefit of caffeine restriction in relieving mastalgia 16. 
MISCELLANEOUS FACTORS 
               Mastalgia had a  positive association with degree of ductal 
dilatation, as supported by ultrasound scan in a study conducted by Peters 
et al17. 
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EMBRYOLOGY OF BREAST 
                   Breasts develop from mammary ridges which extend from the 
axilla to inguinal region by the end of 6th week of gestation. This ridges or  the 
milk lines wont persist in later days and disappears. The part of the pectoral 
region is retained giving raise to breasts. 
                       The breast develops when the ingrowth forms a primary tissue 
bud in mesenchyme. The primary bud, initiates the development of sixteen to 
twenty secondary buds. Epithelial cords arise from those secondary buds and 
extend well into the surrounding mesenchyme. Major ducts/lactiferous ducts 
develop and open into a shallow mammary pit. During infancy, the 
mesenchyme proliferates and transforms the mammary pit into a nipple. The 
breast will be underdeveloped in the female until puberty, then it enlarges to 
ovarian estrogen and progesterone stimuli, which kick starts the proliferation 
of the epithelial and connective tissue components. However, the breasts 
remain in a state of incomplete developement until pregnancy. 
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FIG 1. MILK LINES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
FUNCTIONAL ANATOMY OF BREAST 
             The breasts consist of mammary glands and associated skin and 
connective tissues. The mammary glands are modified sweat glands in the 
superficial fascia anterior to the pectoral muscles and the anterior thoracic 
wall. The base, or attached surface, of each breast extends vertically from ribs 
II to VI, and transversely from the lateral border of sternum to as far laterally 
as the mid-axillary line. The upper lateral region of the breast can project 
around the lateral margin of the pectoralis major muscle and into the axilla. 
This axillary process (axillary tail) may perforate deep fascia and extend as 
far superiorly as the apex of the axilla. 
                      The mammary glands consist of a series of ducts and associated 
secretory lobules. These converge to form 15 to 20 lactiferous ducts, which 
open independently onto the nipple. Each duct has a dilated portion, the 
lactiferous sinus, in which a small droplet of milk accumulates or remains in 
the nursing mother. The nipple is surrounded by a circular pigmented area of 
skin termed the areola. The areola contains numerous sebaceous glands, which 
enlarge during pregnancy and secrete an oily substance that provides a 
protective lubricant for the areola and nipple. The nipples are conical or 
cylindrical prominences in the centre of the areola. The nipples have no fat, 
hair, or sweat glands.  
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                The tips of the nipples are fissured with the lactiferous ducts 
opening into them. The nipples are composed mostly of circularly arranged 
smooth muscle fibres that compress the lactiferous ducts during lactation and 
erect the nipples in response to stimulation, as when a baby begins to suckle. 
                        A well-developed, connective tissue stroma surrounds the 
ducts and lobules of the mammary gland. In certain regions, this condenses to 
form well-defined ligaments, the suspensory ligaments of breast, which are 
continuous with the dermis of the skin and support the breast.  
                        The breast lies on deep fascia related to the pectoralis major, 
serratus anterior and the aponeurosis of external oblique muscle. The deep 
pectoral fascia envelops the pectoralis major muscle and is continuous with 
the deep abdominal fascia below. It attaches to the sternum medially and to 
the clavicle and axillary fascia above and laterally. Along the lateral border of 
the pectoralis major muscle, the anterior lamina of the deep pectoral fascia 
unites with the fascia of the pectoralis minor muscle and, more inferiorly, with 
the fascia of the serratus anterior. A posterior extension of this fascia is 
continuous with the fascia of the latissimus dorsi and forms the suspensory 
ligament of the axilla. A layer of loose connective tissue (the retromammary 
space) separates the breast from the deep fascia and provides some degree of 
movement over underlying structures.  
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                       For the anatomical location and description of tumors and cysts, 
the surface of the breast is divided into four quadrants (fig. 2). The upper outer 
quadrant of the breast contains a greater volume of tissue than do the other 
quadrants. 
FIG 2.  FOUR ANATOMICAL QUADRANTS OF BREAST 
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NIPPLE-AREOLA COMPLEX 
The epidermis of the nipple-areola complex is pigmented very much 
when compared to the surrounding. At puberty, this pigment becomes 
darker and the nipple assumes an elevated position. Then in pregnancy, the 
areolar region enlarges and pigmentation is further increased in intensity. 
The areola also contains sweat glands, sebaceous glands, and 
Montgomery's tubercles (accessory glands, which produce small 
elevations on the surface of the areola). Smooth muscle bundle fibres, lie 
in a circumferential fashion inside the dense connective tissue and 
longitudinally inturn along the course of major ducts. They were 
responsible for the nipple erection in response to sensory stimuli. The 
dermal papilla which is located at the tip of the nipple has been provided 
with numerous sensory nerve endings and Meissner's corpuscles. This rich 
sensory innervation of the breast is of physiological importance, because 
the sucking of the child evokes a neurohormonal response that results in 
milk ejection. 
INACTIVE AND ACTIVE BREAST: 
                     Each lobe of the breast ends in lactiferous duct (0.2 to 0.4 cm 
in diameter).  
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The lactiferous ducts then opens through a narrowed orifice (0.2 to 0.35 
mm in radius) into the ampulla of the nipple areola complex. Lactiferous 
sinus is the distal dialated portion of the lactiferous duct that lies below the 
nipple areola complex. It has the lining of stratified squamous epithelium. 
Lactiferous ducts / major ducts are lined by 2 layers of cuboidal cells. The 
minor ducts are in contrast lined by a single layer of columnar or cuboidal 
cells.  
The Myoepithelial cells arise from ectoderm and they reside between 
the epithelial cells in the basal lamina. Myoepithelial cells contain 
myofibrils which inturn are responsible for milk ejection. Inactive breast, 
the epithelium is sparse and less. In the early phases of the menstrual cycle 
in women, minor ducts are cord-like structures with small lumina. The 
estrogen stimulation occuring at the time of ovulation, causes the alveolar 
epithelium to increase in height and the duct lumen becomes more 
prominent with accumulation of some secretions. As the hormonal 
stimulation stops at the end, the alveolar epithelium regresses in height.  
During pregnancy in women, the breast goes through proliferative 
changes, ductal maturation and increase in size in response to hormonal 
stimulus. The lymphocytes and plasma cells from circulation accumulate 
within the connective tissues. The minor ducts gives off branches and the 
alveoli develop from these branches.  
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Development of the alveoli is asymmetric, and there is a considerable 
degree of variation in the development within a single lobule. Following 
the delivery of child, the breasts gains additional volume by means of 
hypertrophy. Then secretory products accumulate in the lumina of the 
minor ducts.  
Alveolar epithelium contains abundant of some cell organelles like 
mitochondria, Golgi complexes and dense lysosomes.  
Function of the alveolar epithelium in the production of milk:  
(a) Endoplasmic reticulum produces the protein component of the milk 
(b) Lipid component of milk, are produced as free lipid droplets in the 
cytoplasm.  
Milk secreted during the first few days after parturition is called 
colostrums or witch milk. Colustrum has very low lipid content but rich in 
terms of antibodies. The lymphocytes and plasma cells which accumulated 
in the ductal lumen during the physiological phase are the source of the 
antibodies. In the next few weeks the number of cells decrease and the 
lipid-rich milk is released from nipple. 
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FIG 3. BREAST ANATOMY-SAGITTAL SECTION 
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BLOOD SUPPLY OF BREAST: 
The breast receives its principal arterial blood supply from  
(a) perforating branches of the internal thoracic (or internal mammary) artery, 
a branch of the subclavian artery; it courses parallel with the lateral border of the 
sternum behind the transversus thoracis muscles. From the internal thoracic 
artery, perforating branches pass through the intercostal muscles of the first six 
interspaces and the pectoralis major muscle to supply the medial half of the breast 
and surrounding skin. Typically these arteries descend laterally toward the nipple-
areolar complex so that most of the arterial supply arises above the level of the 
nipple. Therefore, radial incisions in the upper half of the breast are less likely to 
injure the major arterial supply than transverse incisions. The inferior parts of the 
breast below the level of the nipple are almost free of major vessels. 
(b) lateral branches of the posterior intercostal arteries; and 
(c) branches from the axillary artery, including the highest thoracic, lateral 
thoracic, pectoral branches of the thoracoacromial artery and unnamed mammary 
branches. The lateral thoracic artery is the most important of these vessels. 
The second, third, and fourth anterior intercostal perforators and branches of 
the internal mammary artery arborize in the breast as the medial mammary 
arteries. 
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The veins of the breast and chest wall follow the course of the arteries, with 
venous drainage being toward the axilla. The three principal groups of veins are  
(a) perforating branches of the internal thoracic vein - The perforating 
tributaries from the medial half of the breast carry the greater part of the venous 
drainage. They enter the internal thoracic vein, which joins the brachiocephalic 
vein. 
(b) perforating branches of the posterior intercostal veins, and 
(c) tributaries of the axillary vein. 
Batson's vertebral venous plexus, which invests the vertebrae and extends 
from the base of the skull to the sacrum, may provide a route for breast cancer 
metastases to the vertebrae, skull, pelvic bones, and central nervous system. 
FIG 4. BLOOD SUPPLY OF BREAST 
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NERVE SUPPLY: 
               Lateral cutaneous branches of the third through sixth intercostal 
nerves provide sensory innervation of the breast (lateral mammary branches) 
and of the anterolateral chest wall. Cutaneous branches that arise from the 
cervical plexus, specifically the anterior branches of the supraclavicular nerve, 
supply a limited area of skin over the upper portion of the breast. The 
intercostobrachial nerve is the lateral cutaneous branch of the second 
intercostal nerve and may be visualized during surgical dissection of the axilla. 
Resection of the intercostobrachial nerve causes loss of sensation over the 
medial aspect of the upper arm. 
LYMPHATIC DRAINAGE OF BREAST: 
                  The lymphatic flow of the breast is of great clinical significance 
because metastatic dissemination occurs principally by the lymphatic routes. 
The dominant lymphatic drainage of the breast is derived from the dermal 
network. The breast lymphatics branch extensively and do not contain valves: 
lymphatic blockage through tumour occlusion may therefore result in reverse 
blood flow through the lymphatic channels. The direction of lymphatic flow 
within the breast parallels the major venous tributaries and  enters the regional 
lymph nodes via the extensive periductal and perilobular network of lymphatic 
channels. Lymph passes from the nipple, areola, and lobules of the gland to 
the subareolar lymphatic plexus.  
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From this plexus most lymph (> 75%), especially from the lateral breast 
quadrants, drains to the axillary lymph nodes, initially to the anterior or 
pectoral nodes for the most part. However, some lymph may drain directly to 
other axillary nodes or even to interpectoral, deltopectoral, supraclavicular, or 
inferior deep cervical nodes. 
Axillary nodes are 20–40 nodes, grouped artificially as pectoral 
(anterior), subscapular (posterior), central and apical. Surgically, the nodes are 
described in relation to pectoralis minor. Those lying below pectoralis minor 
are the low nodes (level 1), those behind the muscle are the middle group 
(level 2), while the nodes between the upper border of pectoralis minor and 
the lower border of the clavicle are the upper or apical nodes (level 3).There 
are six axillary lymph node groups recognized by surgeons 
 (a) the axillary vein group (lateral); 
 (b) the external mammary group (anterior or pectoral group),  
 (c) the scapular group (posterior or subscapular),  
 (d) the central group, 
 (e) the subclavicular group (apical),   and  
(f) the interpectoral group (Rotter's nodes),  
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FIG.5 AXILLARY LYMPH NODES: 
 
Lymph from the axillary nodes drains into clavicular (infraclavicular 
and supraclavicular) lymph nodes and from them into the subclavian 
lymphatic trunk, which also drains lymph from the upper limb. Efferent 
vessels directly from the breast pass round the anterior axillary border through 
the axillary fascia to the pectoral lymph nodes; some may pass directly to the 
subscapular nodes. A few vessels pass from the superior part of the breast to 
the apical axillary nodes, sometimes interrupted by the infraclavicular nodes 
or by small, inconstant, interpectoral nodes.  
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Lymphatic vessels occasionally follow lateral cutaneous branches of the 
posterior intercostal arteries to the intercostal nodes. 
           Lymph from the skin of the breast, except the nipple and areola, drains 
into the ipsilateral axillary, inferior deep cervical, and infraclavicular lymph 
nodes and also into the parasternal lymph nodes of both sides. Dermal 
lymphatics penetrate pectoralis major to join channels that drain the deeper 
parenchymal tissues, and then follow the vascular channels to terminate in the 
subclavicular lymph nodes. Part of the medial side of the breast drains towards 
the internal thoracic group of lymph nodes whereas lymph from the inferior 
quadrants may pass deeply to abdominal lymph nodes (subdiaphragmatic 
inferior phrenic lymph nodes). The internal thoracic chain may drain inferiorly 
via the superior and inferior epigastric lymphatic routes to the groin. 
Connecting lymphatics across the midline may provide access of lymphatic 
flow to the opposite axilla. Lymph from the parasternal nodes enters the 
bronchomediastinal lymphatic trunk, which also drains lymph from the 
thoracic viscera. The termination of these lymphatic trunks varies; 
traditionally, these trunks are described as merging with each other and with 
the jugular lymphatic trunk, draining the head and neck to form a short right 
lymphatic duct on the right side or entering the termination at the thoracic duct 
on the left side.  
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However, in many cases, the trunks open independently into the junction of 
the internal jugular and subclavian vein, the venous angle, to form the 
brachiocephalic veins. In some cases, they open into both of these veins.  
 
FIG 6. LYMPHATICS OF BREAST 
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PHYSIOLOGY OF THE BREAST 
BREAST DEVELOPMENT AND FUNCTION 
Breast development and function are initiated by a variety of 
hormonal stimuli, which includes the estrogen, progesterone, prolactin, 
oxytocin, thyroid hormone, cortisol, and growth hormone. Estrogen, 
progesterone, and prolactin especially have trophic effects that are 
essential to breast development and function. Estrogen is responsible for 
ductal development, whereas progesterone is responsible for 
differentiation of epithelium and lobular development. Prolactin is the 
hormonal stimulus for lactogenesis in pregnancy and the postpartum 
period. It up regulates hormone receptors and also stimulates epithelial 
development. Figure 7 depicts the secretion of neurotrophic hormones 
from hypothalamus, which inturn is responsible for regulation of the 
secretion of the hormones that affect the breast tissues.  
The luteinizing hormone (LH) and follicle - stimulating hormone 
(FSH) regulates the release of estrogen and progesterone from the ovaries. 
The release of LH and FSH from the basophilic cells of the anterior 
pituitary is regulated by the secretion of gonadotropin-releasing hormone 
(GnRH) from hypothalamus.  
Positive and negative feedback mechanisms regulate the secretion 
of LH, FSH, and GnRH. These hormones together are responsible for the 
development, function, and maintenance of breast tissues. 
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 In female neonate, the circulating estrogen and progesterone levels 
decrease after birth and remain low throughout childhood period because 
of the sensitivity of the hypothalamic-pituitary axis to the negative 
feedback mechanisms from these hormones. With the beginning of 
puberty, there is a decrease in the sensitivity of the hypothalamic-pituitary 
axis to negative feedback mechanisms and an increase in its sensitivity to 
positive feedback mechanism to estrogen. These physiologic events causes 
an increase in GnRH, FSH, and LH secretion and resultant increase in 
estrogen and progesterone secretion by the ovaries, which inturn leads to 
establishment of the menstrual cycle. At the beginning of the menstrual 
cycle, the breast increase in the size and density. With the onset of 
menstruation, the breast engorgement and epithelial proliferation 
decreases. 
   PREGNANCY, LACTATION, AND SENESCENCE 
A dramatic increase in circulating ovarian and placental estrogens 
and progestins are evident during pregnancy, which causes alterations in 
the form and substance of the breast. The breast increases in size and 
density as the ductal and lobular epithelium proliferates.  
The areolar skin darkens, and the accessory areolar glands 
(Montgomery's glands) become more prominent. In the 1st and 2nd 
trimesters, the minor ducts branch and develop.  
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During the 3rd trimester, fat droplets accumulates in the alveolar 
epithelium and colostrum fills the alveolar and ductal spaces. In late 
pregnancy, prolactin initiate the synthesis of milk fats and protein. 
After delivery of the placenta, circulating progesterone and estrogen 
levels falls, prolactin expresses its lactogenic action. Milk production and 
secretion are controlled by neural reflex arcs that begin in nerve endings of 
the nipple-areola complex. Maintenance of lactation needs regular 
stimulation of these neural reflexes, which stimulates prolactin secretion 
and milk letdown. 
Oxytocin release is initiated by the auditory, visual, and olfactory 
stimuli associated with the process of nursing. Oxytocin results in 
contraction of the myoepithelial cell and expulsion of milk. After weaning 
of the infant, prolactin and oxytocin levels decreases. Dormant milk results 
in increased pressure within the ducts and alveoli, which causes atrophy of 
the epithelium.  
With the onset of menopause there is a decrease estrogen and  
Progesterone secretions by the ovaries and involution of the ducts and 
alveoli of the breast tissue occurs. The surrounding fibrous connective 
tissue increases and breast tissues is replaced by adipose tissues. 
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FIG 7. NEUROEDOCRINE CONTROL OF MILK 
REFLUX 
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INFECTIOUS AND INFLAMMATORY DISORDERS: 
Except during the postpartum period, infections of the breast are 
rare. They are classified as: 
 Intrinsic (secondary to abnormalities in the breast)  
 Extrinsic (secondary to an infection in the adjacent structure, 
e.g., skin, thoracic cavity). 
BACTERIAL INFECTION 
Staphylococcus aureus and Streptococcus are the most frequent 
organisms found in nipple discharge from an infected breast. Breast 
abscesses (typically staphylococcal infections)  presents with tenderness, 
erythema, and hyperthermia. These abscesses have positive correlation to 
lactation and occur within the few weeks of breastfeeding. The 
staphylococcal infection progress and results in subcutaneous, subareolar, 
interlobular and retromammary abscesses, which needs to be drained. 
Before drainage ultrasonography is effective in delineating the required 
extent of the drainage area. Drainage is done with a circumareolar incisions 
or incisions paralleling Langer's lines.  
Staphylococcal infections tend to be more localized and occurs in 
the deeper parts of the breast tissues, while streptococcal infections usually 
present diffusely in the superficial layers.  
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They are treated with local wound care, including application of 
warm compresses, and with administration of IV antibiotics (penicillins or 
cephalosporins). Breast infections may be chronic, with recurrent abscess 
formation. Cultures are performed to identify acid-fast bacilli, anaerobic 
and aerobic bacteria, and fungi. Biopsy of the abscess cavity wall is 
recommended at the time of drainage to rule out underlying breast cancer 
with necrotic tumor. Hospital-acquired puerperal infections are less 
common nowadays, but lactating women who presents with milk stasis or 
non infectious inflammation may still develop this problem. Epidemic 
puerperal mastitis is initiated by virulent strains of methicillin-resistant S. 
Aureus(MRSA) that are transmitted by the suckling neonate and may result 
in considerable morbidity and occasional mortality.  
Purulent fluid may be expressed from the nipple. In these cases, 
breastfeeding is stopped, IV antibiotics started, and surgical therapy is 
initiated. Nonepidemic (sporadic) puerperal mastitis is the infection of the 
interlobular connective tissue of the breast. The patient develops nipple 
fissuring and milk stasis, which causes a bacterial infection in retrograde 
fashion. Breasts are emptied using breast suction pumps, which shortens 
the duration of symptoms and reduces the recurrences rates. The initiation 
of antibiotic therapy results in a satisfactory outcome in nearly  >95% of 
cases. 
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Zuska's disease (recurrent periductal mastitis), is the recurrent 
retroareolar infections, abscesses and duct fistulas located near nipple.This 
syndrome is managed symptomatically, by IV antibiotics incision and 
drainage as and when required. Long-term control can be obtained by wide 
débridement of chronically infected tissue and/or terminal duct resection. 
But postoperative infections are worrisome. Smoking has been a risk factor 
for this condition. 
MYCOTIC INFECTIONS: 
                  Fungal infections of the breast are uncommon and usually 
caused by blastomycosis or sporotrichosis. Intraoral fungi are inoculated 
into the breast tissue by the suckling neonate. These  present as mammary 
abscesses in close proximity to the nipple-areola complex. Pus mixed with 
blood may be expressed from sinus tracts. Antifungal agents are 
administered for the treatment of systemic (noncutaneous) infections. This 
therapy generally eliminates the need for surgical intervention, but some 
may benefit from drainage of an abscess, or even partial mastectomy, to 
eradicate the persistent fungal infection. Candida albicans of the breast 
skin presents as erythematous, scaly lesions of the inframammary or 
axillary folds. Scrapings from the lesions can be used to demonstrate fungal 
elements.  
Therapy usually involves the removal of predisposing factors such as 
maceration and the topical application of nystatin. 
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HIDRADENITIS SUPPURATIVA 
               Hidradenitis suppurativa of the nipple-areola complex or axilla is 
a chronic inflammatory condition that originates in the accessory areolar 
glands of Montgomery or within the axillary sebaceous glands. Chronic 
acne is a predisposing factor for developing hidradenitis. When located in 
and around the nipple - areola complex, this disease may be difficult to 
distinguish from other chronic inflammatory conditions, Paget's disease of 
the nipple, or invasive breast cancer. Involvement of the axillary skin is 
often contiguous and multifocal. Treatment involves Antibiotic therapy 
with incision and drainage of fluctuant areas. Sometimes excision of the 
involved areas may be required. Large areas of skin loss may require 
coverage with advancement flaps or split-thickness skin grafts.  
MONDOR'S DISEASE: 
                        Mondor's disease (variant of thrombophlebitis) is a rare 
condition that involves inflammation of the superficial veins of the anterior 
chest wall and breast.  
            Mondor described the condition as "string phlebitis".  An inflamed 
and thrombosed vein presenting as a tender, cord -like structure. 
Frequently involves the lateral thoracic vein, the thoraco epigastric vein 
and the superficial epigastric vein. Typically, the woman presents with 
acute pain in the lateral aspect of the breast or in the anterior chest wall.  
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A tender, firm cord like structure is found to follow the distribution of one 
of the major superficial veins. Rarely, bilateral presentation may be seen, 
and there may be no evidence of thrombophlebitis in other anatomic sites. 
This benign, disorder is not indicative of a cancer. When the diagnosis is 
doubtful, or when a mass like lesion is present near the tender cord, biopsy 
is indicated.  
                 Treatment for Mondor's disease includes anti-inflammatory 
medications and application of warm fomentation along the symptomatic 
vein. Other measures include brassiere support as well as restriction of 
motion of the ipsilateral extremity and shoulder. The process usually 
resolve in 4 to 6 weeks. If they are refractory to therapy, excision of the 
involved vein segment is indicated. 
BENIGN DISORDERS AND DISEASES OF THE BREAST: 
Benign breast disorders and diseases encompass a wide spectrum of 
clinical and pathologic entities.  
Surgeons need an in-depth knowledge of these disorders and 
diseases so that a clear explanation and appropriate treatment can be given 
to affected individual  and unnecessary long -term follow up can be 
avoided. 
 
 
 
34 
 
ABERRATIONS OF NORMAL DEVELOPMENT AND 
INVOLUTION: 
The principles guiding the classification of the aberrations of normal 
development and involution (ANDI) of benign breast conditions are as 
follows:  
(a) Benign breast disorders and diseases are related to the normal processes 
of reproductive life and to involution.  
(b) There is a spectrum of breast conditions that ranges from normal to 
disorder to disease.  
(c) The ANDI classification encompasses all aspects of the breast 
condition, including pathogenesis and the degree of abnormality.  
The horizontal row of Table-1 defines ANDI along a spectrum from 
normal, to mild abnormality (disorder), to severe abnormality (disease).  
The vertical component indicates the period during which the condition 
develops. 
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TABLE -1   (ANDI CLASSIFICATION OF BENIGN BREAST 
DISORDERS) 
 NORMAL DISORDER DISEASE 
Early 
reproductive 
years 
(age 15-25years) 
Lobular 
Development 
Fibroadenoma Giant 
Fibroadenoma 
Stromal 
Development 
Adolescent 
hypertrophy 
Gigantomastia 
Nipple eversion Nipple inversion Subareolar abscess 
  Mammary duct 
fistula 
Late reproductive 
years 
(age 25-40yrs) 
Cyclical changes of 
menstruation 
Cyclical mastalgia Incapacitating 
mastalgia 
 Nodularity  
Epithelial 
hyperplasia of 
pregnancy 
Bloody nipple 
discharge 
 
Involution 
(age 35-55years) 
Lobular involution Macrocysts  
 Sclerosing lesions  
Duct involution   
Dilatation Duct ectasia Periductal mastitis 
Sclerosis Nipple retraction  
Epithelial turnover Epithelial 
hyperplasia 
Epithelial 
hyperplasia with 
atypia 
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   EARLY REPRODUCTIVE YEARS 
Fibroadenomas are commonly seen younger women aged between 
15 to 25 years. Fibroadenomas usually grow to 1 or 2 cm in diameter and 
then remain stable but may grow to a larger size. Small fibroadenomas (1 
cm in size) are considered normal, whereas larger fibroadenomas (3 cm) 
are considered a disorder. Giant fibroadenomas (>3 cm) are disease. 
Similarly, multiple fibroadenomas (with more than 5 lesions in one breast) 
are very uncommon and are considered disease. The precise etiology of 
adolescent breast hypertrophy is not known. A spectrum of changes from 
limited to massive stromal hyperplasia (gigantomastia) is seen. Nipple 
inversion is a developmental disorder of the major ducts, which prevents 
normal protrusion of the nipple. Mammary duct fistulas occurs when 
nipple inversion predisposes to major duct obstruction, inturn leading to 
recurrent subareolar abscess. 
LATER REPRODUCTIVE YEARS 
Cyclical mastalgia and nodularity usually are associated with 
premenstrual enlargement of the breast and are considered normal. 
Cyclical mastalgia and severe painful nodularity are viewed differently 
when compared to the physiologic discomfort and lumpiness.  
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Painful nodularity persisting for more than a week of the menstrual 
cycle is considered a disorder.  
INVOLUTION 
Involution of lobular epithelium is dependent on the specialized 
stroma surrounding it. However, an integrated involution of breast stroma 
and epithelium is not always seen, and disorders of the involution are 
common. When the stroma involution is too quick, alveoli remain and form 
microcysts, which may lead to macrocysts. Macrocysts are common and 
are often subclinical. They do not require any specific treatment. 
Sclerosing adenosis is a disorder of both the proliferative and the 
involutional phases of the breast developement. Duct ectasia (dilated 
ducts) and periductal mastitis are also included in ANDI classification. 
Periductal fibrosis is a sequela of periductal mastitis, which results in 
nipple retraction. Sixty percent of women aged 70 may exhibit some 
degree of epithelial hyperplasia. Atypical proliferative diseases include 
ductal and lobular hyperplasia, both display some features of carcinoma in 
situ. Women having atypical ductal or lobular hyperplasia are in fourfold 
risk for breast cancer (Table-2). 
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TABLE-2 ( RELATIVE CANCER RISK ASSOCIATED WITH 
BENIGN BREAST DISORDERS AND IN SITU CARCINOMA 
OF THE BREAST) 
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TABLE-3 (CLASSIFICATION OF BENIGN BREAST 
DISORDERS)
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PATHOLOGY OF NONPROLIFERATIVE DISORDERS 
                         The histologic differentiation of benign, atypical, and               
malignant changes is of paramount importance for management of benign 
breast diseases. Determining the clinical significance of these changes is a 
problem that is compounded by inconsistent nomenclature.  
The classification system was originally developed by Page26, which separates 
the various types of benign breast disorders and diseases into three clinical 
groups: 
1. Nonproliferative disorders 
2. Proliferative disorders without atypia 
3. Proliferative disorders with atypia . 
 Nonproliferative disorders of the breast account for about 70% of benign 
breast conditions and carry no increased risk of breast cancer. This category 
includes cysts, fibroadenomas, duct ectasia, periductal mastitis, calcifications 
and related disorders. 
Breast macrocysts are considered involutional disorder, have a high 
frequency of occurrence, and are often multiple. Duct ectasia is characterized 
by dilated subareolar ducts that are palpable and associated with thick nipple 
discharge.  
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                  Haagensen regarded duct ectasia as a primary event which leads  
to the stagnation of secretions, epithelial ulceration and resultant leakage of 
duct secretions (containing chemically irritating fatty acids) into periductal 
tissue. 
This sequence produces a local inflammatory process with periductal 
fibrosis which results in nipple retraction. Another theory considers periductal 
mastitis as a primary process, which leads to weakening and secondary 
dilatation of ducts. It is possible that both processes occur together which 
explains the wide spectrum of problems seen, including nipple discharge, 
nipple retraction, inflammatory masses, and abscesses. 
Calcium deposits are frequently seen in the breast. Most are benign and 
are due to cellular secretions and debris or may be due to trauma and 
inflammation. Calcifications that are strongly associated with cancer include 
microcalcifications, which vary in shape and density (<0.5 mm in size) and 
fine, linear calcifications, which may show branching. Fibroadenomas tend to 
have abundant stroma with histologically normal cellular elements. They are 
hormonal dependent similar to that of normal breast lobule.They lactate 
during pregnancy and involute in the postmenopausal period. 
 Adenomas of the breast are well circumscribed and are made up of 
benign epithelium with sparse stroma, which differentiates them from 
fibroadenomas26. 
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They may be divided into tubular adenomas and lactating adenomas. 
Tubular adenomas occurs in young non pregnant women, 
Whereas lactating adenomas occurs during pregnancy or during the 
postpartum period. Hamartomas are discrete breast tumors which are usually 
2 to 4 cm in diameter, firm in consistency and sharply circumscribed. 
Adenolipomas are sharply circumscribed nodules of fatty tissue that has 
elements of normal breast lobules and duct. 
FIBROCYSTIC DISEASE 
The term fibrocystic disease is nonspecific. Frequently, it is used to 
describe symptoms, to rationalize the need for breast biopsy, and to explain 
breast biopsy results. Synonyms include chronic cystic disease, chronic cystic 
mastitis, fibrocystic changes, cystic mastopathy, Schimmelbusch's disease, 
mazoplasia, fibroadenomatosis, Reclus' disease, and Cooper's disease26. 
Fibrocystic disease refers to a spectrum of histopathologic changes that are 
best diagnosed and treated specifically. 
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PATHOLOGY OF PROLIFERATIVE DISORDERS WITHOUT  
CELLULAR ATYPIA: 
Proliferative breast disorders without atypia include ductal epithelial 
hyperplasia, sclerosing adenosis, radial scars, complex sclerosing lesions and 
intraductal papillomas. Sclerosing adenosis is commonly seen during the 
reproductive and perimenopausal years and has no malignant potential.  
Histological changes consist of ductal proliferation (proliferative), 
epithelial regression & stromal fibrosis (involutional). Sclerosing adenosis is 
causes distortion of breast lobular architecture and multiple microcysts 
predispose to this condition. It can sometimes present as a palpable mass. 
Benign calcifications are seen. Central sclerosis, apocrine metaplasia, 
epithelial proliferation and papilloma formation leads to the formation of 
radial scars to complex sclerosing lesions of the breast.  
Radial scars are lesions less than 1cm in diameter, whereas larger ones are 
called complex sclerosing lesions. Radial scars are formed at sites of terminal 
duct branching (histological changes found to be radiating from a central area 
of fibrosis). 
               All of the histological features of larger complex sclerosing lesions 
are similar to radial scars, but there is a greater disturbance of papilloma 
formation, apocrine metaplasia, and occasionally sclerosing adenosis. 
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Mild ductal hyperplasia is characterized by the presence of three or four 
cell layers above the basement membrane. Moderate ductal hyperplasia is 
characterized by the presence of five or more cell layers above the basement 
membrane. Florid ductal epithelial hyperplasia occupies at least 70% of a 
minor duct lumen. It is found in >20% of breast tissue specimens, is either 
solid or papillary, and is associated with an increased cancer risk (see Table-
2).  
Intraductal papillomas arise from the major ducts of breast tissue, 
usually in premenopausal women. They generally are of size <0.5 cm in 
diameter but can grow as large as 5 cm. The presenting symptom is nipple 
discharge, which is either serous or bloody. On gross examination, intraductal 
papillomas are pinkish, friable and attached to the wall of the involved duct 
by a stalk. They have a very less malignant potential and it is not a risk for 
developing breast cancer (unless accompanied by atypia). However, multiple 
intraductal papillomas in younger women, which are less frequently 
associated with nipple discharge, have an increased risk of malignant 
transformation. 
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PATHOLOGY OF ATYPICAL PROLIFERATIVE DISEASES 
The atypical proliferative diseases have some of the features of 
carcinoma in situ but lack a major defining feature of carcinoma. In 1978, 
Haagensen and colleagues described lobular neoplasam as a spectrum of 
disorders ranging from atypical lobular hyperplasia to lobular carcinoma in 
situ (LCIS).  
CLINICAL ASSESSMENT AND INVESTIGATIONS 
A detailed history and clinical examination will point to the diagnosis 
in most cases.  
       INVESTIGATIONS  
 Ultrasound examination is done in all patients presenting with mastalgia. 
 Mammogram is done in women aged 40 years and above. 
  FNAC is done in patients with clinically palpable lump or nodularity        
and in patients with ultrasound findings of abnormalities. 
 Patients with FNAC reports of fibroadenoma with lump size >3cm went 
in for excision biopsy. 
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BREAST IMAGING MODALITIES 
MAMMOGRAPHY: 
Screening:  
               Mammography, is suitable for screening especially in women above 
40yrs of age. 
Diagnostic:  
               Mammography is indicated as a diagnostic method in determining 
whether a lesion has a malignant potential or benign. It also screens for occult 
disease found in the surrounding tissue. 
CONVENTIONAL MAMMOGRAPHY 
               Mammography is practically a high-resolution x-ray imaging of 
compressed breast. This process involves radiation transmission through the 
breast tissue and the eventual projection of anatomical structures on a film 
screen/image sensor. 
Two views of each breast,  
 Craniocaudal (CC) view 
 Mediolateral oblique (MLO - 450) view  
are obtained by mammography. 
Additional views may fashioned for individual cases based on the location of 
breast lesion. 
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Misconceptions regarding the risk of radiation from mammography 
persist, despite the fact that no women has shown to develop breast cancer 
as a result of mammography. Studies show even after multiple 
examinations at doses much higher than the current dose of 3 to 4 mGy 
(0.3– 0.40 rad) has no positive correlation with development of breast 
cancer. The adverse effects of screening include pain and discomfort 
(breast compression), patient recall to do additional imaging and false-
positive biopsies. The risk benefit ratio from screening, are in favour of 
detecting early lesions21. 
                    The sensitivity of mammography depends on the patient 
factor like composition and density of the tissue. It is difficult to look for 
small lesions in denser tissue, even though some small foci of calcification 
can be seen. Initially, mammogram is used to detect any mass or 
calcifications followed by architectural distortion. 
A mass by definition is a space occupying lesion imaged in two 
different views in mammography. It is further categorized by its shape, 
margins, density, size, orientation and calcifications. 
Micro calcifications are seen as bright dot-spots on screening 
mammograms, usually in the form of clusters. These are nothing but 
calcium deposits from cell secretion and necrotic debris. The shape and the 
distribution of calcifications in breast tissue indicate malignancy.  
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Benign micro calcifications are usually smooth and sharply defined 
and have high uniform density. Malignant micro calcifications appear in 
irregular shape and are variably distributed through breast tissue23, 24. 
In the official BI-RADS publication, the calcifications have been 
described by its appearance and distribution in the breast tissue23, 24, 25. 
TABLE-4 ADVANTAGES AND LIMITATIONS OF 
MAMMOGRAPHY 
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FIG:8 MAMMOGRAPHY OF BREAST SHOWING DIFFERENT 
DENSITIES: 
 
 
FIG:9 COMPOSITION A HAS LOW RISK, WHILE B &C HAVE MEDIUM 
RISK AND COMPOSITION D HAVE HIGH RISK FOR DEVELOPING 
BREAST CANCER 
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ULTRASONOGRAPHY OF BREAST: 
                USG is mainly used as a cheap and efficient tool to differentiate 
cystic lesion from solid breast masses. USG can be safely performed in young 
or pregnant patients as it do not produce any form of ionizing radiation.  USG 
is useful in detecting breast masses which are hidden on mammogram and to 
evaluate breast lesions in younger women especially less than 30yrs of age.  
Abnormalities demonstrated on the mammogram can further be followed up 
using USG. USG is also a useful tool in the guidance of therapeutic procedures 
and biopsies.  
Women younger than 30years have dense glandular breast tissue which 
reduces the diagnostic sensitivity of mammogram, but USG is especially useful 
in these cases. Evaluation of breast abscesses is better done with USG. Fine 
needle aspiration cytology (FNAC) of the lesion can be done under ultrasound 
guidance.  
The overall sensitivity of ultrasound in detecting breast lumps was 92.5%. 
The sensitivity of ultrasound in detection of palpable breast lumps was 95%. 
However its role in diagnosis of carcinoma of the breast needs further 
evaluation before it can be used for screening of carcinoma breast. 
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TABLE-5 ADVANTAGES AND LIMITATIONS OF USG:  
 
FIG:10 USG OF A BREAST CYST: 
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FIG:11 USG DIFFERENTIATION BETWEEN 
BENIGN AND MALIGNANT LESIONS: 
    
 
 
FNAC: 
                 Fine needle aspiration cytology (FNAC) of the palpable breast masses 
has become a well accepted diagnostic technique. It provides a sensitive and 
economical method of obtaining cytological material for examination. It can be 
done during an OPD visit without the need of anesthesia thus eliminating the cost 
of outpatient surgery. 
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PROCEDURE:  
                     The patient is informed about the procedure and informed consent 
obtained from the patient before subjecting to fine needle aspiration cytology of 
the breast lump. The standard procedure was followed, making use of a 10ml 
syringe bearing a 22-gauze needle. The mass is located clinically and fixed in 
position with free hand. The skin over the puncture site is sterilized with spirit or 
betadine. The needle is placed over the skin and its direction determined before 
it is introduced in the mass in one swift motion.  This minimized the discomfort 
to the patient. Once the tumor is engaged full vacuum is applied, while the needle 
is moved back and forth in the mass with short strokes. The syringe is observed 
for appearance of any specimen. When this appeared, the syringe pistol is slowly 
released and allowed to return to the neutral position. The needle is then 
withdrawn from the mass. The needle is temporarily removed from the apparatus, 
and the syringe is filled with air by pulling back the plunger. The needle is 
reattached, and the specimen is expressed on to a glass slide. It is then immersed 
in a fixative 95% methyl alcohol.  
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FIG:12 FNAC OF BREAST: 
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FIG:13  FIBROADENOMA (FNAC) 
       
 
FIG:14 DUCTAL CARCINOMA IN SITU: 
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RESULTS 
AGE AND MASTALGIA: 
TABLE-6 AGE DISTRIBUTION 
AGE NUMBER OF 
PATIENTS 
PERCENTAGE 
15-20 44 22% 
21-25 78 39% 
26-30 42 21% 
31-35 22 11% 
36-40 10 5% 
41-45 4 2% 
 
CHART-1 SPLIT UP BASED ON CLINICAL EXAMINATIONS: 
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TABLE-7 AGE GROUP CORRELATIONS: 
AGE GROUP 
CLINICAL EXAMINATION USG AND FNAC 
N
A
D
 
N
O
D
U
L
A
R
IT
Y
 
L
U
M
P
 
A
B
C
E
S
S
 
N
A
D
 
F
C
 
F
A
D
 
A
B
C
E
S
S
 
15-20(44pts) 26 8 10 - 24 10 10 - 
21-25(78pts) 46 18 10 4 44 20 10 4 
26-30(42pts) 30 10 2 - 30 10 2 - 
31-35(22pts) 7 10 5 - 7 10 5 - 
36-40(10pts) 3 2 5 - 3 2 5 - 
41-45(4pts) 4 0 0 - 4 0 0 - 
TOTAL(200pts) 116 48 32 4 112 52 32 4 
 
CHART-2 SPLIT UP BASED ON USG AND FNAC RESULTS: 
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LUMP AND MASTALGIA: 
TABLE-8 LUMP AND MASTALGIA 
LUMP NUMBER OF 
PATIENTS 
(n=200) 
PERCENTAGE 
Present 84 42% 
Absent 116 58% 
 
CHART-3 LUMP AND MASTALGIA 
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CYCLICITY OF MASTALGIA: 
TABLE-9 CYCLICITY OF MASTALGIA: 
TYPE OF 
MASTALGIA 
NUMBER OF 
PATIENTS 
(n=200) 
PERCENTAGE 
Cyclical 88 44% 
Non Cyclical 112 56% 
 
CHART-4 CYCLICITY OF MASTALGIA: 
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CHART-5 CORRELATION BETWEEN CYCLICITY AND CLINICAL 
EXAMINATION FINDINGS: 
 
CHART-6 CORRELATION BETWEEN CYCLICITY AND USG&FNAC 
FINDINGS: 
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MENSTURAL CYCLE AND MASTALGIA: 
TABLE-10 MENSTURAL CYCLE AND MASTALGIA 
MENSTURAL 
CYCLES 
NUMBER OF 
PATIENTS 
(n=200) 
PERCENTAGE 
REGULAR 142 71% 
IRREGULAR 58 29% 
 
 
CHART-7 MENSTURAL CYCLE AND MASTALGIA: 
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CHART-8 CORRELATION BETWEEN MENSTURAL CYCLE AND 
CLINICAL EXAMINATION FINDINGS: 
 
CHART-9 CORRELATION BETWEEN MENSTURAL CYCLE AND 
USG&FNAC FINDINGS: 
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PREVIOUS BENIGN BREAST DISEASES: 
CHART-10 PREVIOUS BENIGN BREAST DISEASES: 
 
CHART-11 CLINICAL EXAMINATION FINDINGS IN INDUVIDUALS 
WITH PREVIOUS HISTORY OF BENIGN BREAST DISEASES: 
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CHART-12 USG AND FNAC FINDINGS IN INDUVIDUALS WITH 
PREVIOUS HISTORY OF BENIGN BREAST DISEASES: 
 
 Among the 74pts presented with previous history of benign breast diseases 
46pts found to have pathological and radiological findings (37pts with 
fibrocystic disease, 5pts with fibroadenoma and 4pts with abscess). 
 Among the 126pts presented with previous history of benign breast 
diseases 42pts found to have pathological and radiological findings (15pts 
with fibrocystic disease and 27pts with fibroadenoma). 
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BREAST FEEDING AND MASTALGIA: 
 Breast feeding history is not applicable in 50% of  unmarried 
patients(100pts). 
 Out of the remaining 100 patients, 94(47%) gave positive breastfeeding 
history 
 Only 6 (3%)patients didn’t breastfeed.  
 
CHART-13 BREASTFEEDING AND MASTALGIA: 
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CLINICAL EXAMINATION IN PATIENTS WHO PRESENTED WITH 
COMPLAINTS OF LUMP BREAST: 
 97pts (48%) presented with complaints of breast lump/lumpiness. 
 84pts (42%) were found to have lump/nodularity/abcess on clinical 
examination. 
 48pts (24%) had nodularity on clinical examination. 
 32pts (16%) had lump breast on clinical examination. 
 4pts (2%) had abscess on clinical examination.  
 
CHART-14 CLINICAL EXAMINATION FINDINGS: 
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USG CORRELATION: 
 97pts (48%) presented with complaints of breast lump/lumpiness. 
 84pts (42%) were found to have lump/nodularity/abscess on clinical 
examination. 
 88pts (44%) were found to have lump/nodularity/abscess in USG. 
 52pts (26%) had fibrocystic disease on USG. 
 32pts (16%) had fibroadenoma on USG. 
 4pts (2%) had abscess on USG.  
 
CHART-15 USG CORRELATION: 
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FNAC CORRELATION: 
 88pts (44%) were found to have lump/nodularity/abscess in USG. 
 Among them 84pts (42%) went in for FNAC (except the 4pts with abscess). 
 52pts (26%) had fibrocystic disease on FNAC. 
 32pts (16%) had fibroadenoma on FNAC.  
TABLE-11 FNAC CORRELATION: 
FNAC 
FINDINGS 
NUMBER OF 
PATIENTS 
PERCENTAGE 
NOT APPLICABLE 116 58% 
FC 52 26% 
FAD 32 16% 
 
CHART-16 FNAC CORRELATION 
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EXCISION BIPOPSYCORRELATION: 
 32pts who had fibroadenoma in USG and FNAC went in for excision 
biopsy. 
 28pts had fibroadenoma. 
 2pts had fibrocystic changes. 
 2pts had Ductal Carcinoma In Situ (DCIS).  
TALBE-12 EXCISIONAL BIOPSY REULTS 
EXISIONAL 
BIOPSY  RESULTS 
NUMBER OF 
PATIENTS 
PERCENTAGE 
NOT APPLICABLE 168 84% 
FC 2 1% 
FAD 28 14% 
DCIS 2 1% 
 
CHART-17 EXISIONAL BIOPSY RESULTS: 
            
 
 
168
2
28
2
NA
FC
FAD
DCIS
0 50 100 150 200
BIOPSY FINDINGS
BIOPSY FINDINGS
70 
 
DISCUSSION 
 
AGE AND MASTALGIA: 
 Mastalgia is more prevalent among women of reproductive age.  
 The range of ages involved that are included in this study is between 15and 
45 years.(TABLE-6) . 
 The average age of patients presenting in our series is 25.7 years.The 
median age is 24 years. 
 In Cardiff breast clinic study also corresponds to similar observations that 
mastalgia is more a disease of women of reproductive age group. 
  The median age of their age group was 36 years and their study population 
included 212 women (age ranging between 12 and 51 years)11.  
 The results shows 122 patients were in the age group of 25 or less. 
 These results highlight the fact that 4 cases (2%) was diagnosed by USG 
which were apparently got left out in clinical examination. Interestingly all 
the 4 cases fall below the age of 25yrs.(TABLE-7). 
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CYCLICITY AND MASTALGIA: 
 Breast pain can be classified as cyclical and non-cyclical in relation to their 
occurrence with menstrual cycle.  
 Cyclical mastalgia occurs 1-2 weeks prior to mensus and often bilateral, 
diffusely involves the whole of the breast with occasional radiation to the 
upper arm and axilla.  
 Cyclical mastalgia is usually seen among women 30-40 years of age.  
 It is found to be relieved spontaneously with onset of mensus in nearly 22% 
of patients and being persistent in 65% of patients despite treatment. 
 Among the 88pts presented with cyclical pain 31pts found to have 
pathological and radiological findings (27pts with fibrocystic disease and 
4pts with abscess). 
 Among the 112pts presented with non cyclical pain 57pts found to have 
pathological and radiological findings (25pts with fibrocystic disease and 
32pts with fibroadenoma). 
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TABLE-13 SPLIT UP OF LESIONS IN RELATION TO CYCLICITY: 
CYCLICITY OF 
MASTALGIA 
CLINICAL 
EXAMINATION 
USG AND FNAC 
N
A
D
 
N
O
D
U
L
A
R
IT
Y
 
L
U
M
P
 
A
B
C
E
S
S
 
N
A
D
 
F
C
 
F
A
D
 
A
B
C
E
S
S
 
CYCLICAL 
(88pts) 
59 25 0 4 57 27 0 4 
NON CYCLICAL 
(112pts) 
57 23 32 0 55 25 32 0 
TOTAL 
(200pts) 
116 48 32 4 112 52 32 4 
 
 In a study conducted by srivastav et al non-cyclical mastalgia is slightly 
more prevalent than cyclical mastalgia in women of north india. 
  In our study too similar results observed, that is non-cyclical mastalgia is 
found to be slightly more prevalent than cyclical mastalgia.  
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MENSTURAL CYCLE AND MASTALGIA: 
 It is popularly believed that when breast pain due to altered hormonal status 
occurs in women due to engorgement and ductal dilatation it is logical to 
think that uterus function in relation to this hormonal disarray should also 
be altered which can manifests as irregular menstrual cycles. 
 But this is not supported by the results observed as in our study.  
 Most of the patients have regular menstrual cycles (71%). 
 Among the 142pts presented with regular cycles 79pts found to have 
pathological and radiological findings (45pts with fibrocystic disease, 
30pts with fibroadenoma and 4pts with abscess). 
 Among the 58pts presented with irregular cycles 9pts found to have 
pathological and radiological findings (7pts with fibrocystic disease and 
2pts with fibroadenoma). 
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TABLE-14 SPLIT UP OF LESIONS IN INDUVIDUALS BASED ON 
MENSTRUAL HISTORY: 
MENSTURAL CYCLE CLINICAL EXAMINATION USG AND FNAC 
N
A
D
 
N
O
D
U
L
A
R
IT
Y
 
L
U
M
P
 
A
B
C
E
S
S
 
N
A
D
 
F
C
 
F
A
D
 
A
B
C
E
S
S
 
REGULAR  (142pts) 66 42 30 4 63 45 30 4 
IRREGULAR (58pts) 50 6 2 0 49 7 2 0 
TOTAL 
(200pts) 
116 48 32 4 112 52 32 4 
 
 Out of the 200 patients who underwent the study 142 patients (71%) had 
regular cycles. 
 58patients (29%) had irregular cycles on eliciting history. 
 
 Srivastav et al conducted a similar study in north Indian women and 
observed similar results. 
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PREVIOUS HISTORY AND MASTALGIA: 
TABLE-15 PREVIOUS HISTORY OF BENIGN BREAST DISEASES: 
HISTORY NUMBER OF 
PATIENTS 
PERCENTAGE 
Present 74 37% 
Absent 126 63% 
 
 Previous history of benign breast symptoms is found to have a frequent 
association with the patients currently presenting with mastalgia.  
 History of previous benign diseases for which the patient had received 
medical or surgical treatment is elicited in 37% of individuals in our study. 
TABLE-16 SPLIT UP OF LESIONS IN INDUVIDUALS WITH 
PREVIOUS HISTORY OF BENIGN BREAST DISEASES: 
PREVIOUS 
HISTORY 
CLINICAL EXAMINATION USG AND FNAC 
N
A
D
 
N
O
D
U
L
A
R
IT
Y
 
L
U
M
P
 
A
B
C
E
S
S
 
N
A
D
 
F
C
 
F
A
D
 
A
B
C
E
S
S
 
PRESENT 
(74pts) 
31 34 5 4 28 37 5 4 
ABSENT 
(126pts) 
85 14 27 0 84 15 27 0 
TOTAL(200pts) 116 48 32 4 112 52 32 4 
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 Out of the 200 patients who underwent this study 74 (37%) patients had 
positive history of previous benign breast diseases. 
 126 (63%) patients had no such history. 
 This is a significant positive correlation. 
BREASTFEEDING AND MASTALGIA: 
 In an epidemiological study by srivastav et al from AIIMS observed that 
there is no significant relation between breastfeeding and mastalgia. 
 In this study also there was no significant correlation found between 
breastfeeding and mastalgia. 
 In our part of the world breastfeeding practices are strong and most of the 
mothers who participated in the study gave history for breastfeeding. 
TABLE-17 BREAST FEEDING AND MASTALGIA: 
BREAST FEEDING NO OF WOMEN PERCENTAGE 
Given 94 47% 
Not given 6 3% 
Not Applicable 100 50% 
 Only 3% of women have not given breast milk. 
 And this seemingly increased incidence of breast pain among breastfed 
mothers is attributable to the strong breastfeeding practice of women who 
participated in the study.  
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MASTALGIA AND LUMP: 
 Mastalgia as a clinical condition is far more prevalent then lump breast.  
 But lump breast draws the attention of the patient to the previously 
prevalent breast pain and make them to approach a doctor for medical 
advice. 
 In a clinical study published by Kelley et al breast lump is found to be  
associated with breast pain presented in 29% of patients(n= 350 patient).  
 97pts (48%) presented with complaints of breast lump/lumpiness. 
 84pts (42%) were found to have lump/nodularity/abscess on clinical 
examination. 
 88pts (44%) were found to have lump/nodularity/abscess in USG. 
  Among them 84pts (42%) went in for FNAC (except the 4pts with 
abscess). 
 32pts who had fibroadenoma in USG and FNAC went in for excision 
biopsy. 
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TABLE-18 WORKUP IN CASES PRESENTED WITH MASTALGIA 
Patient 
complained 
of 
lumpiness 
Patient 
found to 
have Lump/ 
Nodularity/ 
Abscess on 
clinical 
examination 
Patient found to 
have 
Fibroadenoma/ 
Fibrocystic 
disease/ Abscess 
on USG 
Patient with 
Fibroadenoma/ 
Fibrocystic 
disease in USG 
underwent 
FNAC 
Patients with 
FNAC reports 
of 
Fibroadenoma 
(lump >3cm) 
went for  
Excision 
Biopsy 
Present in 
97pts 
(48%) 
Present in 
84pts 
(42%) 
Present in 88pts 
(44%) 
84pts went in 
for FNAC 
32pts went in 
for Excision 
Biopsy 
 Nodularity 
in 48pts 
FC in 52pts FC in 52pts 28pts had FAD 
 Lump in 
32pts 
FAD in 32pts FAD in 32pts 2pts had FC 
 Abscess in 4 
pts 
Abscess in 4 pts - 2pts had DCIS 
Absent in 
103pts 
(52%) 
Absent in 
116pts 
(58%) 
Absent in 
112pts 
(56%) 
- - 
 
 4pts (2%) with nodularity were missed in clinical examination especially 
in age group below 25yrs. These were picked up by USG. 
 There seems to be a near 100% correlation between USG and FNAC 
establishing the USG superiority in breast lesions. 
 The 32pts with USG and FNAC results as fibroadenoma and lesion more 
than3cm in size underwent excision biopsy and in those:  
 2pts (1%) were found to have fibrocystic changes. 
 2pts (1%) were found to have DCIS.     
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CONCLUSION: 
1.  Non-cyclical mastalgia is more prevalent than cyclical mastalgia among 
women in south India which needs more evaluation. 
2.  Lumpiness of one or both breasts is a frequently associated complaint with 
mastalgia which needed detailed history, clinical examination and 
investigations to differentiate benign from malignant lesions.  
3. Presence of previous history of benign breast diseases or treatment is a risk 
factor for mastalgia which may be due to improper diagnosis and 
management. 
4. USG is the best diagnostic tool in young females as they have dense breasts. 
5. Triple assessment for any breast lump or mastalgia forms gold standard in 
diagnosis. 
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ANEXURE 1- CONSENT FORM
PROFORMA
Name: Op number:
Age:
Sex:
Religion
Occupation
Residence
Chief complaints:
1) Mastalgia
Duration
Side
Cyclical
2) Breast lump:
Side
Duration
3) Nipple changes:
Discharge/recent changes/indrawn
4) H/o trauma, fever
5) Any other complaints:
Past history:
Previous history of Benign breast diseases and treatment
History of drug intake:
Menstrual history:
Age of menarche:
Cycles: Reg/Ireg
Marital history: married/unmarried
Birth control pills:
Menopause:
Hormone replacement therapy:
Past obstetric history:
No of pregnancies:
Age at each pregnancy:
Breastfeeding of each child:
Last child birth:
Total years of breastfeeding:
Family history:
General physical examination:
Vital signs:
Local examination:
RIGHT                                                                                        LEFT
SYSTEMIC EXAMINATION:
CVS
RS
ABDOMEN
PROVISIONAL DIAGNOSIS:
INVESTIGATION:
URINE A/S/D:
CBC:
BLOOD SUGAR: ,UREA: ,CREATININE: .
USG BREAST:
MAMMOGRAPHY:
FNAC:
EXCISIONAL BIOPSY:
FINAL DIAGNOSIS:
SN NAME A
GE
CYCLICAL
PAIN
LUMP OTHER
HISTORY
PREVIOUS
BREAST
DISEASE
CYCLES BREAST
FEEDING
CLINICAL
EXAMINATION
USG FNAC EXCISION
BIOPSY
1 AMBIGA 23 YES YES - YES Reg - NODULARITY FC FC -
2 SELVI 24 YES NO - NO Reg - NAD NAD - -
3 KANAGAVALLI 22 NO NO - NO Ireg - NAD NAD - -
4 KASTURI 32 NO YES - NO Reg YES LUMP FAD FAD FAD
5 KRISHNAVENI 37 YES YES - YES Reg YES NODULARITY FC FC -
6 SUBBU LAKSHMI 27 YES NO - NO Ireg YES NAD NAD - -
7 RANI 25 NO YES - YES Reg YES NODULARITY FC FC -
8 THANGATHAI 24 YES NO G/E MALAISE NO Ireg - NAD NAD - -
9 ESSAKIAMMAL 24 YES YES - YES Reg YES NODULARITY FC FC -
10 UMA 27 NO NO - NO Ireg YES NAD NAD - -
11 PETCHITHAI 25 YES NO H/O TRAUMA NO Reg NO NAD NAD - -
12 MARIYAM 28 YES NO - NO Reg YES NAD NAD - -
13 MURUGESWARI 21 NO NO - NO Ireg - NAD NAD - -
14 CHRISTY REGINA 25 NO YES - NO Reg YES LUMP FAD FAD FAD
15 CHANDRA 24 YES NO - NO Reg - NAD NAD - -
16 KAVITHA 21 NO YES - NO Reg - LUMP FAD FAD FAD
17 AMBIGA 27 YES YES - YES Reg NO NODULARITY FC FC -
18 RANI 28 YES NO - NO Reg YES NAD NAD - -
19 AYYAMMAL 35 NO NO - YES Reg YES NAD NAD - -
20 PARKATHNISHA 21 YES YES - YES Reg - NODULARITY FC FC -
21 JEYA 23 NO NO - NO Ireg - NAD NAD - -
22 USHA 22 YES NO H/O FEVER YES Reg - ABCESS ABCESS - -
23 MADATHI 38 NO YES - YES Reg YES LUMP FAD FAD DCIS
24 ANTONY MARY 25 YES YES - YES Reg YES NODULARITY FC FC -
25 KAVITHA 24 NO NO - NO Reg - NAD NAD - -
26 SELVI 23 NO YES - NO Reg - LUMP FAD FAD FAD
27 PARVATHY 29 NO NO - NO Ireg YES NAD NAD - -
28 SAROJA 24 YES NO - NO Reg YES NAD NAD - -
29 MAARI 29 YES YES - YES Reg YES NODULARITY FC FC -
30 MALIKA 23 YES NO - NO Ireg - NAD NAD - -
31 SUNDARI 33 NO YES - YES Reg YES NODULARITY FC FC -
32 THANGAMARI 25 NO YES - NO Reg YES LUMP FAD FAD FAD
33 FARIYA 21 NO YES - YES Ireg - NODULARITY FC FC -
34 SUMATHI 20 YES NO - NO Reg - NAD NAD - -
35 VALLI 25 NO NO - NO Ireg YES NAD NAD - -
36 LAKSHMI 20 YES NO - NO Reg - NAD NAD - -
37 SAMEENA 19 YES YES - NO Ireg - NODULARITY FC FC -
38 PADMA 24 YES NO - NO Reg - NAD NAD - -
39 THANGASELVI 23 NO NO - NO Ireg - NAD NAD - -
40 NAGOORAMMAL 43 NO NO H/O GIDINESS YES Ireg YES NAD NAD - -
41 KALAIVANI 19 YES NO - NO Reg - NAD NAD - -
42 PAPPA 40 NO NO G/E MALAISE YES Reg YES NAD NAD - -
43 RAGINI 20 NO YES - NO Reg - LUMP FAD FAD FAD
44 AISWARYA 19 YES NO - NO Reg - NAD NAD - -
45 MAHARANI 22 YES YES - YES Reg - NAD FC FC -
46 CHITRAKANI 23 YES NO - NO Reg - NAD NAD - -
47 CHANDRA 19 NO YES - NO Reg - LUMP FAD FAD FAD
48 SHEEBA 27 NO NO H/O TRAUMA NO Ireg YES NAD NAD - -
49 ESAKKIAMMAL 35 NO YES - NO Reg YES NODULARITY FC FC -
50 CHANDRA 29 YES NO - NO Reg YES NAD NAD - -
51 MANJU 25 YES YES - NO Reg YES NODULARITY FC FC -
52 UMA 24 YES NO - NO Reg YES NAD NAD - -
53 SARA 17 NO NO - YES Ireg - NAD NAD - -
54 BALAMMAL 32 NO YES - NO Reg YES LUMP FAD FAD FC
55 MUTHU 25 NO YES - NO Reg - NODULARITY FC FC -
56 SELVARANI 28 NO NO - NO Reg YES NAD NAD - -
57 MALA 18 YES YES - NO Reg - NODULARITY FC FC -
58 MALIKA 25 NO NO - YES Ireg - NAD NAD - -
59 INDRA 25 NO YES - YES Reg - NODULARITY FC FC -
60 RAJALAKSMI 24 NO NO - NO Reg - NAD NAD - -
61 ARUMUGATHAI 23 NO NO - NO Ireg - NAD NAD - -
62 MARY 19 YES NO - YES Reg - NAD NAD - -
63 KARPAGAM 26 NO NO - YES Ireg YES NAD NAD - -
64 PETCHIAMMAL 36 NO YES - YES Reg YES LUMP FAD FAD DCIS
65 MOOKAMMAL 35 NO NO - NO Reg YES NAD NAD - -
66 MUPIDATHI 28 NO YES - YES Ireg YES NODULARITY FC FC -
67 VALLIAMMAL 32 NO YES - NO Reg YES NODULARITY FC FC -
68 MUTHU LAKSHMI 19 NO YES - NO Reg - LUMP FAD FAD FAD
69 JEYASEELA 29 NO NO - NO Reg YES NAD NAD - -
70 CHANDRA 27 NO NO - YES Ireg YES NAD NAD - -
71 DEEPA 19 YES NO - NO Reg - NAD NAD - -
72 RAMALAKSMI 24 YES NO - YES Reg NO ABCESS ABCESS - -
73 OPPACHIAMMAL 40 NO YES - YES Reg YES LUMP FAD FAD FAD
74 SYLVIA 17 YES YES - YES Reg - NODULARITY FC FC -
75 UMA 27 NO NO - NO Ireg YES NAD NAD - -
76 PARVATHY 26 NO NO - YES Ireg YES NAD NAD - -
77 SUMATHI 22 YES NO - NO Reg - NAD NAD - -
78 SAMEERA 19 YES YES YES Ireg - NAD FC FC -
79 VALLIYAMMAL 44 NO NO G/E FATIGABILITY YES Reg YES NAD NAD - -
80 ANNATHAI 29 NO YES - NO Reg YES LUMP FAD FAD FAD
81 SARASWATHY 32 NO YES - YES Reg YES NODULARITY FC FC -
82 JEYARANI 21 NO YES - NO Ireg - LUMP FAD FAD FAD
83 KALA 31 NO YES - NO Reg YES NODULARITY FC FC -
84 MANIMALA 23 YES NO - NO Reg - NAD NAD - -
85 VALLI 24 YES NO - YES Reg - NAD NAD - -
86 STELLA 18 YES NO - NO Ireg - NAD NAD - -
87 PUSHPA 34 NO NO - NO Reg YES NAD NAD - -
88 RANI 27 NO NO - NO Reg YES NAD NAD - -
89 MURUGAMMAL 28 NO YES - YES Reg YES NODULARITY FC FC -
90 SELVI 35 NO NO - YES Reg YES NAD NAD - -
91 KUMARI 20 YES NO - NO Ireg - NAD NAD - -
92 PONESSAKI 29 NO NO - YES Reg YES NAD NAD - -
93 MUTHU LAKSHMI 19 NO YES - NO Reg - LUMP FAD FAD FAD
94 SALOMI 18 YES NO - NO Ireg - NAD NAD - -
95 SATHYA 26 NO YES - YES Reg YES NODULARITY FC FC -
96 PETHCIAMMAL 24 YES NO - NO Reg - NAD NAD - -
97 SYEDALIFATHIMA 17 NO YES - NO Reg - LUMP FAD FAD FAD
98 KALIVANI 15 YES NO - NO Ireg - NAD NAD - -
99 SARANYA 19 YES YES - YES Reg - NODULARITY FC FC -
100 ARUNA 18 YES NO - NO Ireg - NAD NAD - -
101 LAKSMI 28 YES NO - NO Reg YES NAD NAD - -
102 PONNAMAL 35 NO NO - YES Reg YES NAD NAD - -
103 DHIVYA 21 YES YES - YES Reg - NODULARITY FC FC -
104 SUDHA 23 NO NO - NO Ireg - NAD NAD - -
105 MEKALA 22 YES NO H/O FEVER YES Reg - ABCESS ABCESS - -
106 THAMARAI 38 NO YES - YES Reg YES LUMP FAD FAD FAD
107 SAROJA 25 YES YES - YES Reg YES NODULARITY FC FC -
108 VALLI 24 NO NO - NO Reg - NAD NAD - -
109 SUNDARI 23 NO YES - NO Reg - LUMP FAD FAD FAD
110 ALAGU 29 NO NO - NO Ireg YES NAD NAD - -
111 MEENA 24 YES NO - NO Reg YES NAD NAD - -
112 SUBBU 29 YES YES - YES Reg YES NODULARITY FC FC -
113 LEELA 23 YES NO - NO Ireg - NAD NAD - -
114 VASANTHI 33 NO YES - YES Reg YES NODULARITY FC FC -
115 VADIVU 25 NO YES - NO Reg YES LUMP FAD FAD FAD
116 DEEPA 21 NO YES - YES Ireg - NODULARITY FC FC -
117 PONNU 20 YES NO - NO Reg - NAD NAD - -
118 RAGINI 24 NO NO - NO Reg - NAD NAD - -
119 MALIKA 23 NO NO - NO Ireg - NAD NAD - -
120 INDRA 19 YES NO - YES Reg - NAD NAD - -
121 CHITRA 26 NO NO - YES Ireg YES NAD NAD - -
122 RAMALAKSHMI 36 NO YES - YES Reg YES LUMP FAD FAD FAD
123 SUGANYA 35 NO NO - NO Reg YES NAD NAD - -
124 SULEKA 28 NO YES - YES Ireg YES NODULARITY FC FC -
125 SARASWATHY 32 NO YES - NO Reg YES NODULARITY FC FC -
126 RIZWAN 19 NO YES - NO Reg - LUMP FAD FAD FAD
127 JEBARANI 29 NO NO - NO Reg YES NAD NAD - -
128 ANNAM 27 NO NO - YES Ireg YES NAD NAD - -
129 FATHIMA 19 YES NO - NO Reg - NAD NAD - -
130 DURGA 24 YES NO - YES Reg NO ABCESS ABCESS - -
131 THAYAMMAL 40 NO YES - YES Reg YES LUMP FAD FAD FAD
132 ROJA 17 YES YES - YES Reg - NODULARITY FC FC -
133 PARVATHY 27 NO NO - NO Ireg YES NAD NAD - -
134 SUMATHI 26 NO NO - YES Ireg YES NAD NAD - -
135 MARY 22 YES NO - NO Reg - NAD NAD - -
136 ELIZABETH 19 YES YES YES Ireg - NAD FC FC -
137 SANKARAVADIVU 44 NO NO G/E FATIGABILITY YES Reg YES NAD NAD - -
138 SANGEEETHA 29 NO YES - NO Reg YES LUMP FAD FAD FAD
139 SANTHYA 32 NO YES - YES Reg YES NODULARITY FC FC -
140 ALMEENA 21 NO YES - NO Ireg - LUMP FAD FAD FAD
141 SUMITHRA 31 NO YES - NO Reg YES NODULARITY FC FC -
142 MUTHU 23 YES NO - NO Reg - NAD NAD - -
143 MARIYAM 25 NO NO - NO Ireg YES NAD NAD - -
144 BACKIYAM 20 YES NO - NO Reg - NAD NAD - -
145 BANU 19 YES YES - NO Ireg - NODULARITY FC FC -
146 SINDHU 24 YES NO - NO Reg - NAD NAD - -
147 REVATHI 23 NO NO - NO Ireg - NAD NAD - -
148 PETHCHITHAI 43 NO NO H/O GIDINESS YES Ireg YES NAD NAD - -
149 STELLA MARY 19 YES NO - NO Reg - NAD NAD - -
150 VADIVAMMAL 40 NO NO G/E MALAISE YES Reg YES NAD NAD - -
151 PRIYA 20 NO YES - NO Reg - LUMP FAD FAD FAD
152 RENUKA 19 YES NO - NO Reg - NAD NAD - -
153 DEVI 22 YES YES - YES Reg - NAD FC FC -
154 DHARSHINI 23 YES NO - NO Reg - NAD NAD - -
155 KALAIARASI 19 NO YES - NO Reg - LUMP FAD FAD FAD
156 UMA 27 NO NO H/O TRAUMA NO Ireg YES NAD NAD - -
157 ABMBIGA 35 NO YES - NO Reg YES NODULARITY FC FC -
158 ESTHER 29 YES NO - NO Reg YES NAD NAD - -
159 VIJAYA 25 YES YES - NO Reg YES NODULARITY FC FC -
160 POOMARI 24 YES NO - NO Reg YES NAD NAD - -
161 SUBHA 17 NO NO - YES Ireg - NAD NAD - -
162 KANNAMAL 32 NO YES - NO Reg YES LUMP FAD FAD FC
163 SUGUNA 25 NO YES - NO Reg - NODULARITY FC FC -
164 PRIYA 28 NO NO - NO Reg YES NAD NAD - -
165 MURUGESH 18 YES YES - NO Reg - NODULARITY FC FC -
166 MARISWARI 25 NO NO - YES Ireg - NAD NAD - -
167 SREERAJI 25 NO YES - YES Reg - NODULARITY FC FC -
168 THANGAMARI 24 YES NO - YES Reg - NAD NAD - -
169 DIANA 18 YES NO - NO Ireg - NAD NAD - -
170 ANNABAKIYAM 34 NO NO - NO Reg YES NAD NAD - -
171 THEEPA 27 NO NO - NO Reg YES NAD NAD - -
172 KAVITHA 28 NO YES - YES Reg YES NODULARITY FC FC -
173 RAMANI 35 NO NO - YES Reg YES NAD NAD - -
174 THERSA 20 YES NO - NO Ireg - NAD NAD - -
175 RAJAMMAL 29 NO NO - YES Reg YES NAD NAD - -
176 VINOTHA 19 NO YES - NO Reg - LUMP FAD FAD FAD
177 SURYA 18 YES NO - NO Ireg - NAD NAD - -
178 PARAMESWARI 26 NO YES - YES Reg YES NODULARITY FC FC -
179 MARIYATHAI 24 YES NO - NO Reg - NAD NAD - -
180 THOOYAMATHI 17 NO YES - NO Reg - LUMP FAD FAD FAD
181 KIRUBA 15 YES NO - NO Ireg - NAD NAD - -
182 NITHYA 19 YES YES - YES Reg - NODULARITY FC FC -
183 MALAR 18 YES NO - NO Ireg - NAD NAD - -
184 ESWARI 23 YES YES - YES Reg - NODULARITY FC FC -
185 THILAGAVATHY 24 YES NO - NO Reg - NAD NAD - -
186 KRITHIKA 22 NO NO - NO Ireg - NAD NAD - -
187 CHANDRA 32 NO YES - NO Reg YES LUMP FAD FAD FAD
188 PITCHAMMAL 37 YES YES - YES Reg YES NODULARITY FC FC -
189 MANIMEGALAI 27 YES NO - NO Ireg YES NAD NAD - -
190 PAVITHRA 25 NO YES - YES Reg YES NODULARITY FC FC -
191 AISHA 24 YES NO G/E MALAISE NO Ireg - NAD NAD - -
192 NANDHINI 24 YES YES - YES Reg YES NODULARITY FC FC -
193 PANDESSWARI 27 NO NO - NO Ireg YES NAD NAD - -
194 RAHAMAT 25 YES NO H/O TRAUMA NO Reg NO NAD NAD - -
195 POOMA 28 YES NO - NO Reg YES NAD NAD - -
196 PARVATHY 21 NO NO - NO Ireg - NAD NAD - -
197 ESSAKITHAI 25 NO YES - NO Reg YES LUMP FAD FAD FAD
198 MARESWARI 24 YES NO - NO Reg - NAD NAD - -
199 BHARATHI 21 NO YES - NO Reg - LUMP FAD FAD FAD
200 VELLAMMAL 27 YES YES - YES Reg NO NODULARITY FC FC -
ANEXURE 1- CONSENT FORM
PROFORMA
Name: Op number:
Age:
Sex:
Religion
Occupation
Residence
Chief complaints:
1) Mastalgia
Duration
Side
Cyclical
2) Breast lump:
Side
Duration
3) Nipple changes:
Discharge/recent changes/indrawn
4) H/o trauma, fever
5) Any other complaints:
Past history:
Previous history of Benign breast diseases and treatment
History of drug intake:
Menstrual history:
Age of menarche:
Cycles: Reg/Ireg
Marital history: married/unmarried
Birth control pills:
Menopause:
Hormone replacement therapy:
Past obstetric history:
No of pregnancies:
Age at each pregnancy:
Breastfeeding of each child:
Last child birth:
Total years of breastfeeding:
Family history:
General physical examination:
Vital signs:
Local examination:
RIGHT LEFT
SYSTEMIC EXAMINATION:
CVS
RS
ABDOMEN
PROVISIONAL DIAGNOSIS:
INVESTIGATION:
URINE A/S/D:
CBC:
BLOOD SUGAR: ,UREA: ,CREATININE: .
USG BREAST:
MAMMOGRAPHY:
FNAC:
EXCISIONAL BIOPSY:
FINAL DIAGNOSIS:
SN NAME A
G
E
CYCLICAL
PAIN
LUMP OTHER
HISTORY
PREVIOUS
BREAST
DISEASE
CYCLES BREAST
FEEDING
CLINICAL
EXAMINATION
USG FNAC EXCISION
BIOPSY
1 AMBIGA 23 YES YES - YES Reg - NODULARITY FC FC -
2 SELVI 24 YES NO - NO Reg - NAD NAD - -
3 KANAGAVALLI 22 NO NO - NO Ireg - NAD NAD - -
4 KASTURI 32 NO YES - NO Reg YES LUMP FAD FAD FAD
5 KRISHNAVENI 37 YES YES - YES Reg YES NODULARITY FC FC -
6 SUBBU LAKSHMI 27 YES NO - NO Ireg YES NAD NAD - -
7 RANI 25 NO YES - YES Reg YES NODULARITY FC FC -
8 THANGATHAI 24 YES NO G/E MALAISE NO Ireg - NAD NAD - -
9 ESSAKIAMMAL 24 YES YES - YES Reg YES NODULARITY FC FC -
10 UMA 27 NO NO - NO Ireg YES NAD NAD - -
11 PETCHITHAI 25 YES NO H/O TRAUMA NO Reg NO NAD NAD - -
12 MARIYAM 28 YES NO - NO Reg YES NAD NAD - -
13 MURUGESWARI 21 NO NO - NO Ireg - NAD NAD - -
14 CHRISTY REGINA 25 NO YES - NO Reg YES LUMP FAD FAD FAD
15 CHANDRA 24 YES NO - NO Reg - NAD NAD - -
16 KAVITHA 21 NO YES - NO Reg - LUMP FAD FAD FAD
17 AMBIGA 27 YES YES - YES Reg NO NODULARITY FC FC -
18 RANI 28 YES NO - NO Reg YES NAD NAD - -
19 AYYAMMAL 35 NO NO - YES Reg YES NAD NAD - -
20 PARKATHNISHA 21 YES YES - YES Reg - NODULARITY FC FC -
21 JEYA 23 NO NO - NO Ireg - NAD NAD - -
22 USHA 22 YES NO H/O FEVER YES Reg - ABCESS ABCESS - -
23 MADATHI 38 NO YES - YES Reg YES LUMP FAD FAD DCIS
24 ANTONY MARY 25 YES YES - YES Reg YES NODULARITY FC FC -
25 KAVITHA 24 NO NO - NO Reg - NAD NAD - -
26 SELVI 23 NO YES - NO Reg - LUMP FAD FAD FAD
27 PARVATHY 29 NO NO - NO Ireg YES NAD NAD - -
28 SAROJA 24 YES NO - NO Reg YES NAD NAD - -
29 MAARI 29 YES YES - YES Reg YES NODULARITY FC FC -
30 MALIKA 23 YES NO - NO Ireg - NAD NAD - -
31 SUNDARI 33 NO YES - YES Reg YES NODULARITY FC FC -
32 THANGAMARI 25 NO YES - NO Reg YES LUMP FAD FAD FAD
33 FARIYA 21 NO YES - YES Ireg - NODULARITY FC FC -
34 SUMATHI 20 YES NO - NO Reg - NAD NAD - -
35 VALLI 25 NO NO - NO Ireg YES NAD NAD - -
36 LAKSHMI 20 YES NO - NO Reg - NAD NAD - -
37 SAMEENA 19 YES YES - NO Ireg - NODULARITY FC FC -
38 PADMA 24 YES NO - NO Reg - NAD NAD - -
39 THANGASELVI 23 NO NO - NO Ireg - NAD NAD - -
40 NAGOORAMMAL 43 NO NO H/O GIDINESS YES Ireg YES NAD NAD - -
41 KALAIVANI 19 YES NO - NO Reg - NAD NAD - -
42 PAPPA 40 NO NO G/E MALAISE YES Reg YES NAD NAD - -
43 RAGINI 20 NO YES - NO Reg - LUMP FAD FAD FAD
44 AISWARYA 19 YES NO - NO Reg - NAD NAD - -
45 MAHARANI 22 YES YES - YES Reg - NAD FC FC -
46 CHITRAKANI 23 YES NO - NO Reg - NAD NAD - -
47 CHANDRA 19 NO YES - NO Reg - LUMP FAD FAD FAD
48 SHEEBA 27 NO NO H/O TRAUMA NO Ireg YES NAD NAD - -
49 ESAKKIAMMAL 35 NO YES - NO Reg YES NODULARITY FC FC -
50 CHANDRA 29 YES NO - NO Reg YES NAD NAD - -
51 MANJU 25 YES YES - NO Reg YES NODULARITY FC FC -
52 UMA 24 YES NO - NO Reg YES NAD NAD - -
53 SARA 17 NO NO - YES Ireg - NAD NAD - -
54 BALAMMAL 32 NO YES - NO Reg YES LUMP FAD FAD FC
55 MUTHU 25 NO YES - NO Reg - NODULARITY FC FC -
56 SELVARANI 28 NO NO - NO Reg YES NAD NAD - -
57 MALA 18 YES YES - NO Reg - NODULARITY FC FC -
58 MALIKA 25 NO NO - YES Ireg - NAD NAD - -
59 INDRA 25 NO YES - YES Reg - NODULARITY FC FC -
60 RAJALAKSMI 24 NO NO - NO Reg - NAD NAD - -
61 ARUMUGATHAI 23 NO NO - NO Ireg - NAD NAD - -
62 MARY 19 YES NO - YES Reg - NAD NAD - -
63 KARPAGAM 26 NO NO - YES Ireg YES NAD NAD - -
64 PETCHIAMMAL 36 NO YES - YES Reg YES LUMP FAD FAD DCIS
65 MOOKAMMAL 35 NO NO - NO Reg YES NAD NAD - -
66 MUPIDATHI 28 NO YES - YES Ireg YES NODULARITY FC FC -
67 VALLIAMMAL 32 NO YES - NO Reg YES NODULARITY FC FC -
68 MUTHU LAKSHMI 19 NO YES - NO Reg - LUMP FAD FAD FAD
69 JEYASEELA 29 NO NO - NO Reg YES NAD NAD - -
70 CHANDRA 27 NO NO - YES Ireg YES NAD NAD - -
71 DEEPA 19 YES NO - NO Reg - NAD NAD - -
72 RAMALAKSMI 24 YES NO - YES Reg NO ABCESS ABCESS - -
73 OPPACHIAMMAL 40 NO YES - YES Reg YES LUMP FAD FAD FAD
74 SYLVIA 17 YES YES - YES Reg - NODULARITY FC FC -
75 UMA 27 NO NO - NO Ireg YES NAD NAD - -
76 PARVATHY 26 NO NO - YES Ireg YES NAD NAD - -
77 SUMATHI 22 YES NO - NO Reg - NAD NAD - -
78 SAMEERA 19 YES YES YES Ireg - NAD FC FC -
79 VALLIYAMMAL 44 NO NO G/E FATIGABILITY YES Reg YES NAD NAD - -
80 ANNATHAI 29 NO YES - NO Reg YES LUMP FAD FAD FAD
81 SARASWATHY 32 NO YES - YES Reg YES NODULARITY FC FC -
82 JEYARANI 21 NO YES - NO Ireg - LUMP FAD FAD FAD
83 KALA 31 NO YES - NO Reg YES NODULARITY FC FC -
84 MANIMALA 23 YES NO - NO Reg - NAD NAD - -
85 VALLI 24 YES NO - YES Reg - NAD NAD - -
86 STELLA 18 YES NO - NO Ireg - NAD NAD - -
87 PUSHPA 34 NO NO - NO Reg YES NAD NAD - -
88 RANI 27 NO NO - NO Reg YES NAD NAD - -
89 MURUGAMMAL 28 NO YES - YES Reg YES NODULARITY FC FC -
90 SELVI 35 NO NO - YES Reg YES NAD NAD - -
91 KUMARI 20 YES NO - NO Ireg - NAD NAD - -
92 PONESSAKI 29 NO NO - YES Reg YES NAD NAD - -
93 MUTHU LAKSHMI 19 NO YES - NO Reg - LUMP FAD FAD FAD
94 SALOMI 18 YES NO - NO Ireg - NAD NAD - -
95 SATHYA 26 NO YES - YES Reg YES NODULARITY FC FC -
96 PETHCIAMMAL 24 YES NO - NO Reg - NAD NAD - -
97 SYEDALIFATHIMA 17 NO YES - NO Reg - LUMP FAD FAD FAD
98 KALIVANI 15 YES NO - NO Ireg - NAD NAD - -
99 SARANYA 19 YES YES - YES Reg - NODULARITY FC FC -
100 ARUNA 18 YES NO - NO Ireg - NAD NAD - -
101 LAKSMI 28 YES NO - NO Reg YES NAD NAD - -
102 PONNAMAL 35 NO NO - YES Reg YES NAD NAD - -
103 DHIVYA 21 YES YES - YES Reg - NODULARITY FC FC -
104 SUDHA 23 NO NO - NO Ireg - NAD NAD - -
105 MEKALA 22 YES NO H/O FEVER YES Reg - ABCESS ABCESS - -
106 THAMARAI 38 NO YES - YES Reg YES LUMP FAD FAD FAD
107 SAROJA 25 YES YES - YES Reg YES NODULARITY FC FC -
108 VALLI 24 NO NO - NO Reg - NAD NAD - -
109 SUNDARI 23 NO YES - NO Reg - LUMP FAD FAD FAD
110 ALAGU 29 NO NO - NO Ireg YES NAD NAD - -
111 MEENA 24 YES NO - NO Reg YES NAD NAD - -
112 SUBBU 29 YES YES - YES Reg YES NODULARITY FC FC -
113 LEELA 23 YES NO - NO Ireg - NAD NAD - -
114 VASANTHI 33 NO YES - YES Reg YES NODULARITY FC FC -
115 VADIVU 25 NO YES - NO Reg YES LUMP FAD FAD FAD
116 DEEPA 21 NO YES - YES Ireg - NODULARITY FC FC -
117 PONNU 20 YES NO - NO Reg - NAD NAD - -
118 RAGINI 24 NO NO - NO Reg - NAD NAD - -
119 MALIKA 23 NO NO - NO Ireg - NAD NAD - -
120 INDRA 19 YES NO - YES Reg - NAD NAD - -
121 CHITRA 26 NO NO - YES Ireg YES NAD NAD - -
122 RAMALAKSHMI 36 NO YES - YES Reg YES LUMP FAD FAD FAD
123 SUGANYA 35 NO NO - NO Reg YES NAD NAD - -
124 SULEKA 28 NO YES - YES Ireg YES NODULARITY FC FC -
125 SARASWATHY 32 NO YES - NO Reg YES NODULARITY FC FC -
126 RIZWAN 19 NO YES - NO Reg - LUMP FAD FAD FAD
127 JEBARANI 29 NO NO - NO Reg YES NAD NAD - -
128 ANNAM 27 NO NO - YES Ireg YES NAD NAD - -
129 FATHIMA 19 YES NO - NO Reg - NAD NAD - -
130 DURGA 24 YES NO - YES Reg NO ABCESS ABCESS - -
131 THAYAMMAL 40 NO YES - YES Reg YES LUMP FAD FAD FAD
132 ROJA 17 YES YES - YES Reg - NODULARITY FC FC -
133 PARVATHY 27 NO NO - NO Ireg YES NAD NAD - -
134 SUMATHI 26 NO NO - YES Ireg YES NAD NAD - -
135 MARY 22 YES NO - NO Reg - NAD NAD - -
136 ELIZABETH 19 YES YES YES Ireg - NAD FC FC -
137 SANKARAVADIVU 44 NO NO G/E FATIGABILITY YES Reg YES NAD NAD - -
138 SANGEEETHA 29 NO YES - NO Reg YES LUMP FAD FAD FAD
139 SANTHYA 32 NO YES - YES Reg YES NODULARITY FC FC -
140 ALMEENA 21 NO YES - NO Ireg - LUMP FAD FAD FAD
141 SUMITHRA 31 NO YES - NO Reg YES NODULARITY FC FC -
142 MUTHU 23 YES NO - NO Reg - NAD NAD - -
143 MARIYAM 25 NO NO - NO Ireg YES NAD NAD - -
144 BACKIYAM 20 YES NO - NO Reg - NAD NAD - -
145 BANU 19 YES YES - NO Ireg - NODULARITY FC FC -
146 SINDHU 24 YES NO - NO Reg - NAD NAD - -
147 REVATHI 23 NO NO - NO Ireg - NAD NAD - -
148 PETHCHITHAI 43 NO NO H/O GIDINESS YES Ireg YES NAD NAD - -
149 STELLA MARY 19 YES NO - NO Reg - NAD NAD - -
150 VADIVAMMAL 40 NO NO G/E MALAISE YES Reg YES NAD NAD - -
151 PRIYA 20 NO YES - NO Reg - LUMP FAD FAD FAD
152 RENUKA 19 YES NO - NO Reg - NAD NAD - -
153 DEVI 22 YES YES - YES Reg - NAD FC FC -
154 DHARSHINI 23 YES NO - NO Reg - NAD NAD - -
155 KALAIARASI 19 NO YES - NO Reg - LUMP FAD FAD FAD
156 UMA 27 NO NO H/O TRAUMA NO Ireg YES NAD NAD - -
157 ABMBIGA 35 NO YES - NO Reg YES NODULARITY FC FC -
158 ESTHER 29 YES NO - NO Reg YES NAD NAD - -
159 VIJAYA 25 YES YES - NO Reg YES NODULARITY FC FC -
160 POOMARI 24 YES NO - NO Reg YES NAD NAD - -
161 SUBHA 17 NO NO - YES Ireg - NAD NAD - -
162 KANNAMAL 32 NO YES - NO Reg YES LUMP FAD FAD FC
163 SUGUNA 25 NO YES - NO Reg - NODULARITY FC FC -
164 PRIYA 28 NO NO - NO Reg YES NAD NAD - -
165 MURUGESH 18 YES YES - NO Reg - NODULARITY FC FC -
166 MARISWARI 25 NO NO - YES Ireg - NAD NAD - -
167 SREERAJI 25 NO YES - YES Reg - NODULARITY FC FC -
168 THANGAMARI 24 YES NO - YES Reg - NAD NAD - -
169 DIANA 18 YES NO - NO Ireg - NAD NAD - -
170 ANNABAKIYAM 34 NO NO - NO Reg YES NAD NAD - -
171 THEEPA 27 NO NO - NO Reg YES NAD NAD - -
172 KAVITHA 28 NO YES - YES Reg YES NODULARITY FC FC -
173 RAMANI 35 NO NO - YES Reg YES NAD NAD - -
174 THERSA 20 YES NO - NO Ireg - NAD NAD - -
175 RAJAMMAL 29 NO NO - YES Reg YES NAD NAD - -
176 VINOTHA 19 NO YES - NO Reg - LUMP FAD FAD FAD
177 SURYA 18 YES NO - NO Ireg - NAD NAD - -
178 PARAMESWARI 26 NO YES - YES Reg YES NODULARITY FC FC -
179 MARIYATHAI 24 YES NO - NO Reg - NAD NAD - -
180 THOOYAMATHI 17 NO YES - NO Reg - LUMP FAD FAD FAD
181 KIRUBA 15 YES NO - NO Ireg - NAD NAD - -
182 NITHYA 19 YES YES - YES Reg - NODULARITY FC FC -
183 MALAR 18 YES NO - NO Ireg - NAD NAD - -
184 ESWARI 23 YES YES - YES Reg - NODULARITY FC FC -
185 THILAGAVATHY 24 YES NO - NO Reg - NAD NAD - -
186 KRITHIKA 22 NO NO - NO Ireg - NAD NAD - -
187 CHANDRA 32 NO YES - NO Reg YES LUMP FAD FAD FAD
188 PITCHAMMAL 37 YES YES - YES Reg YES NODULARITY FC FC -
189 MANIMEGALAI 27 YES NO - NO Ireg YES NAD NAD - -
190 PAVITHRA 25 NO YES - YES Reg YES NODULARITY FC FC -
191 AISHA 24 YES NO G/E MALAISE NO Ireg - NAD NAD - -
192 NANDHINI 24 YES YES - YES Reg YES NODULARITY FC FC -
193 PANDESSWARI 27 NO NO - NO Ireg YES NAD NAD - -
194 RAHAMAT 25 YES NO H/O TRAUMA NO Reg NO NAD NAD - -
195 POOMA 28 YES NO - NO Reg YES NAD NAD - -
196 PARVATHY 21 NO NO - NO Ireg - NAD NAD - -
197 ESSAKITHAI 25 NO YES - NO Reg YES LUMP FAD FAD FAD
198 MARESWARI 24 YES NO - NO Reg - NAD NAD - -
199 BHARATHI 21 NO YES - NO Reg - LUMP FAD FAD FAD
200 VELLAMMAL 27 YES YES - YES Reg NO NODULARITY FC FC -
LEGEND:
FAD : Fibroadenoma of the Breast
FC : Fibrocystic Disease of the Breast
NAD : No Abnormality Detected
Reg : Regular menstrual cycles
Ireg : Irregular menstrual cycles
USG : Ultrasonography
FNAC : Fine Needle Aspiration Cytology
DCIS : Ductal Carcinoma In Situ
